Caplin Point Laboratories informs about press release
Caplin Point Laboratories has informed that it enclosed press release regarding receipt of final approval by Subsidiary, Caplin Steriles Limited, from the USFDA for the Sodium Phosphates Injection USP
The above information is a part of company’s filings submitted to BSE.
